TCL1A Antibody

說(shuō)明書

中文名稱：

TCL1A兔多克隆抗體
貨號(hào)：

CSB-PA023313GA01HU
規(guī)格：

￥3,900
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

Uniprot No.：

P56279
基因名：

TCL1A
別名：

Anti TCL1A antibody; Lymphoma/leukemia, T-cell antibody; Oncogene TCL-1 antibody; Oncogene TCL1 antibody; P14 TCL1 antibody; P14 TCL1 protein antibody; Protein p14 TCL1 antibody; T cell leukemia 1 antibody; T cell lymphoma 1 antibody; T cell lymphoma 1A antibody; T-cell leukemia/lymphoma 1A antibody; T-cell leukemia/lymphoma protein 1A antibody; TCL 1 protein antibody; TCL1 antibody; TCL1 oncogene antibody; TCL1 PEN antibody; Tcl1a antibody; TCL1A antibody antibody; TCL1A_HUMAN antibody
宿主：

Rabbit
反應(yīng)種屬：

Human,Mouse,Rat
免疫原：

Human TCL1A
免疫原種屬：

Homo sapiens (Human)
抗體亞型：

IgG
純化方式：

Antigen Affinity Purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,WB
Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

Enhances the phosphorylation and activation of AKT1, AKT2 and AKT3. Promotes nuclear translocation of AKT1. Enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival.
基因功能參考文獻(xiàn)：
1. Combination of T-cell lymphoma-1 protein (TCL1)-overexpression and damaging ataxia telangiectasia mutated protein (ATM) functionally synergistically contribute to T-cell prolymphocytic leukemia (T-PLL) specific phenotype of impaired DNA damage processing. PMID: 29449575
2. Case Report: hematogones can express TCL-1 in patients with T-cell prolymphocytic leukemia after therapy. PMID: 28232160
3. TCL1A is not only a useful biomarker for prognostic evaluation in stage II/III colorectal cancer patients. PMID: 28178623
4. Our results suggest that intratumoral TCL1A+ B cells are important for controlling cervical cancer development. PMID: 26299617
5. Our study suggests that TCL1 expression profile may have a role in the prediction of overall outcome in patient with MCL and call for prospective studies. PMID: 25688912
6. We investigated TCL1 expression at the protein level in the bone marrow of a series of 59 patients with Waldenstrom macroglobulinemia: 76% of patients expressed TCL1, which appeared to be associated with a pejorative prognostic impact. PMID: 26493619
7. Suggest miR-181b as therapeutic target for chronic lymphocytic leukemia in the Emicro-TCL1 mouse model. PMID: 26090867
8. High TCL1A expression is associated with chronic lymphocytic leukemia. PMID: 25936528
9. Polymorphic genetic variations of cytochrome P450 19A1 and T-cell leukemia 1A genes in the Tamil population PMID: 25481307
10. Peptide-based TCL1-interphase mimics were potent in steric AKT antagonization. PMID: 25348018
11. demonstrated that miR-3676 targets three consecutive 28-bp repeats within 3'UTR of TCL1 and showed that miR-3676 is a powerful inhibitor of TCL1 PMID: 25646413
12. Case Report: T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRgamma-TCL1A translocation] confirmed by FISH. PMID: 24966976
13. Report frequent TCL1A rearrangements in T-cell prolymphocytic leukemia with cutaneous involvement. PMID: 25310835
14. TCL1-Tg:p53(-/-) leukemia cells exhibit higher survival capacity and are more drug resistant than the leukemia cells from TCL1-Tg:p53wt mice PMID: 23608884
15. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q. PMID: 22875623
16. SNPs near the 3' terminus of TCL1A were associated with aromatase inhibitors-dependent musculoskeletal pain. Estradiol induced SNP-dependent TCL1A expression. PMID: 22405131
17. Data indicate that up-regulated transcription of TCL1A was observed in two cases. PMID: 22553924
18. Our findings reveal a functional interaction between Tcl1 and Hsp70 and identify Tcl1 as a novel Hsp70 client protein PMID: 23160471
19. Intracellular expression of the TCL1 as well as membrane and intracellular expression of ILT7 in plasmacytoid dendritic cell leukemia (pDCL) samples and 61 non-pDC acute leukemia samples, were tested. PMID: 22674796
20. These findings demonstrate that the microenvironment has a proactive role in the regulation of the known signaling enhancer and pro-survival molecule TCL1 in CLL. PMID: 22460735
21. TCL1 is hyperexpressed in multiple B-cell lymphomas. PMID: 22645177
22. 100% of dysgerminomas were positive for TCL1, but all immature teratomas were negative. PMID: 22448662
23. genetic association studies in a Japanese population: Data suggest that a substantial number of patients with T-cell prolymphocytic leukemia exhibit abnormal expression of TCL1A probably due to rearrangement in region of TCL1 gene. PMID: 22189846
24. CLL samples with high Tcl1 expression showed a decrease in DNA methylation compared with CLL samples with low Tcl1 expression PMID: 22308499
25. Using primary chronic lymphocytic leukemia cells we have shown an inverse relationship between TCL1 and PTPROt expression. PMID: 22001392
26. Data indicate an inverse correlation between miR-16-1, miR-181a, miR-181b, and level of expression of TCL-1 and BCL-2, which suggest that these miRNAs may implicate in negatively regulating target mRNA at transcriptional level. PMID: 21130495
27. This study identified 4 single nucleotide polymorphisms related to TCL1A that, when present, were associated with musculoskeletal adverse effects to anastrozole or exemestane treatment in postmenopausal women with stage I to III breast cancer. PMID: 21172079
28. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma. PMID: 20553335
29. TCL1 positivity was predominantly found in germinal center phenotype diffuse large B-cell lymphoma. PMID: 20382409
30. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. PMID: 20357824
31. Immunohistochemical evaluation of TCL1 expression may be useful for substantiating a diagnosis of unclassified type of intratubular germ cell neoplasia or seminoma. PMID: 20395523
32. TCL1 mRNA expression may predict clinical outcome in CLL and that the IGHV3-21 subset, regardless of mutational status, displays high TCL1 expression. PMID: 19889012
33. establish that the association between TCL1A and IkappaB is compatible with AKT binding to TCL1A, but incompatible with IkappaB binding to NF-kappaB PMID: 19668332
34. An exposed hydrophobic patch composed of two discontinuous amino acid stretches has been identified near one end of the TCL1 beta-barrel that is required for TCL1-AKT binding association. PMID: 12009899
35. Increased TCL1 expression correlates with PBC-ALL progression and loss of TEL expression. TCL1 expression is important for the maturation of precursor lymphocytes but not differentiated B or T cells. PMID: 12127395
36. data demonstrate that TCL1 is a powerful oncogene that, when overexpressed in both B and T cells, predominantly yields mature B cell lymphomas PMID: 12381789
37. oncogene transactivation by Sp1 PMID: 12421830
38. results further support derivation of blastic tumors of skin from dendritic cells and demonstrate TCL1 proto-oncogene protein expression in this tumor PMID: 12576313
39. altered expression in Burkitt lymphomas in the presence of Epstein-Barr virus PMID: 12672960
40. Involved in the pathogenesis of mature leukemias and lymphomas: mature T-cell leukemia and chronic lymphocytic leukemia(review) PMID: 15325703
41. Akt kinase activity can be inhibited by a peptide spanning the betaA strand of the proto-oncogene TCL1 PMID: 15459205
42. Detailed mechanism for TCL1-augmented signaling helps explain the delayed occurrence of mature T cell expansions and leukemias despite tumorigenic TCL1 dysregulation that begins in early thymocytes. PMID: 16002684
43. In EBV-negative diffuse large B-cell lymphoma and Burkitt lymphoma-derived cell lines infected in vitro with a recombinant EBV, high expression of EBNA2 inversely correlated with expression of germinal center-associated genes, BCL6 and TCL1. PMID: 17151114
44. Expression levels of microRNA generally inversely correlated with Tcl1 expression in chronic lymphocytic leukemia. PMID: 17178851
45. Biological action of the proto-oncogene TCL1 family and the development avenues for a suppressive drug specific for Akt, a core intracellular survival regulator.[REVIEW] PMID: 17360849
46. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. PMID: 17548807
47. TCL1 expression in B-cell tumors parallels its regulation in non-neoplastic B cells and can be used diagnostically as an indicator of the differentiation stage of a given B-cell tumor. PMID: 17592280
48. TCL1A deregulation may be caused by faulty gene silencing as a potential consequence of losses of 7q miRNAs in splenic marginal zone lymphoma. PMID: 17625607
49. Lower TCL-1 levels were associated with improved complete remission rate and progression-free survival PMID: 17659340
50. TCL1 inhibits activation-induced cell death in T cells by blocking PKCtheta and ERK activation, upon cellular activation PMID: 17846228
顯示更多

收起更多
相關(guān)疾病：

Chromosomal aberrations activating TCL1A are found in chronic T-cell leukemias (T-CLL). Translocation t(14;14)(q11;q32); translocation t(7;14)(q35;q32); inversion inv(14)(q11;q32) that involves the T-cell receptor alpha/delta loci.
亞細(xì)胞定位：

Cytoplasm. Nucleus. Microsome. Endoplasmic reticulum. Note=Microsomal fraction.
蛋白家族：

TCL1 family
組織特異性：

Restricted in the T-cell lineage to immature thymocytes and activated peripheral lymphocytes. Preferentially expressed early in T- and B-lymphocyte differentiation.
數(shù)據(jù)庫(kù)鏈接：

HGNC: 11648

OMIM: 186960

KEGG: hsa:8115

STRING: 9606.ENSP00000385036

UniGene: Hs.2484

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human